Trafalgar International (GCAN) Share-based Compensation (2017 - 2025)
Greater Cannabis Company (GCAN) posted quarterly Share-based Compensation of $1800.0 for Q1 2025, down 85.31% quarter-over-quarter from $12250.0 in Q3 2019.
Trafalgar International (GCAN) Share-based Compensation (2017 - 2025) Analysis & Trends
Greater Cannabis Company's Share-based Compensation history runs 4 years deep, the most recent figure standing at $1800.0 for Q1 2025.
- In Q1 2025, Share-based Compensation changed N/A year-over-year to $1800.0; the TTM figure through Mar 2025 stood at $14050.0 (changed N/A YoY), while the FY2019 annual figure was $88130.0, changed N/A from the prior year.
- Share-based Compensation for Q1 2025 stood at $1800.0, down from $12250.0 in the prior quarter.
- The five-year high for Share-based Compensation was $1800.0 in Q1 2025, with the low at $1800.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 40.00 Mn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 26.00 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 114.12 Mn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 19.00 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 30.40 Mn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 65.00 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 7.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Trafalgar International | 236,233.75 | 236,233.75 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 1,800.00 |
| Mar 31, 2025 | 1,800.00 |
| Sep 30, 2019 | 12,250.00 |
| Sep 30, 2019 | 12,250.00 |
| Mar 31, 2018 | 2,500.00 |
| Mar 31, 2018 | 2,500.00 |
| Dec 31, 2017 | 7,125.00 |
| Dec 31, 2017 | 7,125.00 |
| Sep 30, 2017 | 2,500.00 |
| Sep 30, 2017 | 2,500.00 |
| Jun 30, 2017 | 2,500.00 |
| Jun 30, 2017 | 2,500.00 |
| Mar 31, 2017 | 525,000.00 |
| Mar 31, 2017 | 525,000.00 |